Key Takeaways
- • Carlyle AlpInvest closed AlpInvest Atom Fund II at $1.7bn, exceeding its $1bn fundraising target and hitting its hard cap, with commitments from 26 countries across pension funds, sovereign wealth funds, insurance companies, and family offices.
- • The fund increases Carlyle AlpInvest's total single-asset continuation vehicle (SACV) investment capacity to $7bn when combined with existing secondaries vehicles, evergreen funds, and related sidecar capital.
- • Single-asset continuation vehicles have emerged as one of the fastest-growing segments of the GP-led secondaries market, enabling private equity sponsors to retain ownership of high-performing portfolio companies while offering existing fund investors liquidity options amid slower traditional distribution environments.
- • Carlyle AlpInvest has committed approximately $7bn across 31 SACV transactions since 2018, leveraging its secondaries platform, portfolio finance capabilities, and proprietary data on private companies to source and evaluate deals.
- • The strategy focuses primarily on North America and Western Europe, with the firm citing long-standing relationships with private equity managers as a competitive advantage in underwriting continuation vehicle transactions.
Summary
Carlyle AlpInvest has successfully completed the final close of AlpInvest Atom Fund II, its second dedicated single-asset continuation vehicle, raising $1.7bn and surpassing its original $1bn target. The fund closed at its hard cap, reflecting robust institutional investor demand for GP-led secondaries strategies. The fundraising drew commitments from a geographically diverse base of 26 countries, encompassing pension funds, sovereign wealth funds, insurance companies, banks, endowments, foundations, and family offices.
The new vehicle expands Carlyle AlpInvest's total investment capacity for single-asset continuation vehicle transactions to $7bn when aggregated with the firm's existing secondaries vehicles, evergreen funds, and related sidecar capital. This scaling demonstrates the manager's strategic focus on a market segment experiencing accelerating growth as private equity sponsors seek flexible alternatives to traditional exit routes.
Single-asset continuation vehicles have become one of the fastest-growing segments of the GP-led secondaries market, driven by a slowdown in traditional distributions and the need for private equity firms to provide liquidity solutions to existing fund investors while retaining control of high-performing portfolio companies. Carlyle AlpInvest's SACV strategy invests primarily in sponsor-backed companies across North America and Western Europe, leveraging the firm's broader secondaries platform, portfolio finance capabilities, and primary fund investment business to identify and underwrite opportunities.
Since 2018, Carlyle AlpInvest has committed approximately $7bn across 31 SACV transactions, positioning itself as an established player in this market segment. The firm attributes its competitive advantages to long-standing relationships with private equity managers and extensive proprietary data on private companies, which inform its transaction sourcing and underwriting processes. The oversubscription of Atom Fund II and the firm's continued expansion of SACV capacity underscore sustained institutional appetite for continuation vehicle strategies as a core component of diversified secondaries portfolios.
The new vehicle expands Carlyle AlpInvest's total investment capacity for single-asset continuation vehicle transactions to $7bn when aggregated with the firm's existing secondaries vehicles, evergreen funds, and related sidecar capital. This scaling demonstrates the manager's strategic focus on a market segment experiencing accelerating growth as private equity sponsors seek flexible alternatives to traditional exit routes.
Single-asset continuation vehicles have become one of the fastest-growing segments of the GP-led secondaries market, driven by a slowdown in traditional distributions and the need for private equity firms to provide liquidity solutions to existing fund investors while retaining control of high-performing portfolio companies. Carlyle AlpInvest's SACV strategy invests primarily in sponsor-backed companies across North America and Western Europe, leveraging the firm's broader secondaries platform, portfolio finance capabilities, and primary fund investment business to identify and underwrite opportunities.
Since 2018, Carlyle AlpInvest has committed approximately $7bn across 31 SACV transactions, positioning itself as an established player in this market segment. The firm attributes its competitive advantages to long-standing relationships with private equity managers and extensive proprietary data on private companies, which inform its transaction sourcing and underwriting processes. The oversubscription of Atom Fund II and the firm's continued expansion of SACV capacity underscore sustained institutional appetite for continuation vehicle strategies as a core component of diversified secondaries portfolios.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.